---
title: Best EBM articles in 2005
author: Steve Simon
source: http://www.pmean.com/06/EbmArticles2005.html
date: 2006-03-06
categories:
- Blog post
tags:
- Teaching resources
output: html_document
page_update: partial
---

One of the regular contributors to the Evidence Based Health email
discussion group asked what we felt were the Best EBM methods papers in
2005. I'll report on the articles that people suggest. Here are a few
that I like:

1.  **Medical journals are an extension of the marketing arm of
    pharmaceutical companies.** R. Smith. PLoS Med 2005: 2(5); e138.
    [\[Medline\]](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15916457&dopt=Abstract)
    [\[Full
    text\]](http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020138)
    [\[PDF\]](http://medicine.plosjournals.org/perlserv/?request=get-pdf&file=10.1371_journal.pmed.0020138-L.pdf)
    **(Evidence, Corroboration, Conflict)**
2.  **Contradicted and initially stronger effects in highly cited
    clinical research.** J. P. Ioannidis. Jama 2005: 294(2); 218-28.
    [\[Medline\]](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16014596&dopt=Abstract)
    **(Evidence, General)**
3.  **Randomized controlled trials of aprotinin in cardiac surgery:
    could clinical equipoise have stopped the bleeding?** D.
    Fergusson, K. C. Glass, B. Hutton, S. Shapiro. Clin Trials 2005:
    2(3); 218-29; discussion 229-32.
    [\[Medline\]](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16279145&dopt=Abstract)
    [\[Abstract\]](http://www.ingentaconnect.com/content/arn/ct/2005/00000002/00000003/art00004#avail)
    [\[PDF\]](http://docserver.ingentaconnect.com/deliver/cw/arn/17407745/v2n3/s4/p218.pdf?fmt=dirpdf&tt=10307&cl=43&ini=connect&bini=&wis=connect&ac=0&acs=32629,75000325,22076418&expires=1136476037&checksum=9FDEF46EE6EA18C7BB6F457C405B6CC2&cookie=1602592000)
    **(Evidence, Metaanalysis, History)**
4.  **"Is Cybermedicine Killing You?"\--The story of a Cochrane
    disaster.** G. Eysenbach, P. E. Kummervold. J Med Internet Res 2005:
    7(2); e21.
    [\[Medline\]](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15998612&dopt=Abstract)
    [\[Full text\]](http://www.jmir.org/2005/2/e21) **(Evidence,
    Corroboration, Fraud, Retractions)**
5.  **Comparison of descriptions of allocation concealment in trial
    protocols and the published reports: cohort study.** J. Pildal, A.
    W. Chan, A. Hrobjartsson, E. Forfang, D. G. Altman, P. C. Gotzsche.
    Bmj 2005;
    [\[Medline\]](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15817527&dopt=Abstract)
    [\[Abstract\]](http://bmj.bmjjournals.com/cgi/content/abstract/330/7499/1049)
    [\[Full
    text\]](http://bmj.bmjjournals.com/cgi/content/full/330/7499/1049)
    [\[PDF\]](http://bmj.bmjjournals.com/cgi/reprint/330/7499/1049.pdf)
    **(Evidence, Apples, Allocation concealment)**
6.  **Adequacy and reporting of allocation concealment: review of recent
    trials published in four general medical journals.** C. Hewitt, S.
    Hahn, D. J. Torgerson, J. Watson, J. M. Bland. Bmj 2005;
    [\[Medline\]](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15760970&dopt=Abstract)
    [\[Full
    text\]](http://bmj.bmjjournals.com/cgi/content/full/330/7499/1057)
    [\[PDF\]](http://bmj.bmjjournals.com/cgi/reprint/330/7499/1057.pdf)
    **(Evidence, Apples, Allocation concealment)**
7.  **Relative citation impact of various study designs in the health
    sciences.** N. A. Patsopoulos, A. A. Analatos, J. P. Ioannidis. Jama
    2005: 293(19); 2362-6.
    [\[Medline\]](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15900006&dopt=Abstract)
    **(Evidence, General)**
8.  **Selective serotonin reuptake inhibitors: placebo washouts inflate
    antidepressant effects in general practice.** H. W. van Marwijk, H.
    J. Ader. Bmj 2005: 330(7488); 420.
    [\[Medline\]](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15718553&dopt=Abstract)
    [\[Full
    text\]](http://bmj.bmjjournals.com/cgi/content/full/330/7488/420-a)
    [\[PDF\]](http://bmj.bmjjournals.com/cgi/reprint/330/7488/418.pdf)
    **(Evidence, Leftout, Exclusions, Placebo responders)**
9.  **Assessment of methodological quality of primary studies by
    systematic reviews: results of the metaquality cross sectional
    study.** L. P. Moja, E. Telaro, R. D'Amico, I. Moschetti, L.
    Coe, A. Liberati. Bmj 2005;
    [\[Medline\]](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15817526&dopt=Abstract)
    [\[Abstract\]](http://bmj.bmjjournals.com/cgi/content/abstract/bmj.38414.515938.8Fv1)
    [\[PDF\]](http://bmj.bmjjournals.com/cgi/rapidpdf/bmj.38414.515938.8Fv1.pdf)
    **(Evidence, Metaanalysis, Quality scores)**
10. **Identifying outcome reporting bias in randomised trials on PubMed:
    review of publications and survey of authors.** A. W. Chan, D. G.
    Altman. Bmj 2005: 330(7494); 753.
    [\[Medline\]](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15681569&dopt=Abstract)
    [\[Abstract\]](http://bmj.bmjjournals.com/cgi/content/abstract/330/7494/753)
    [\[Full
    text\]](http://bmj.bmjjournals.com/cgi/content/full/330/7494/753)
    [\[PDF\]](http://bmj.bmjjournals.com/cgi/reprint/330/7494/753.pdf)
    **(Evidence, Mountain, Post hoc changes)**

The first article in the list, by Richard Smith, is one among a large
series of articles that identify how commercial interests have made the
entire research endeavor open to question. The second article, by<U+FFFD> John
Ioannidis also calls the entire research endeavor into question and
points out the many factors that cause incorrect conclusions to be drawn
in most published research findings. The third article by Dean Fergusson
and others, argues that we do too much duplicative research that just
confirms what is already well established. The authors cite a particular
example involving placebo controlled trials which raises serious ethical
concerns, because 64 trials were run, but clear and convincing evidence
emerged by the time the 12th study was published. I'll add brief
comments about the remaining seven papers when I have time.

Here's a list of the papers that other people cited:

1.  Alper BS, White DS, Ge B. Physicians answer more clinical questions
    and change clinical decisions more often with synthesized evidence:
    a randomized trial in primary care. Ann Fam Med. 2005
    Nov-Dec;3(6):507-13.
2.  Peter Bogaty; James Brophy. Numbers needed to treat (needlessly?)
    The Lancet; Apr 9-Apr 15, 2005; 365, 9467.
3.  Chan AW, Altman DG Identifying outcome reporting bias in randomised
    trials on PubMed: review of publications and survey of authors. BMJ.
    2005 Apr 2;330(7494):753.
4.  On Making the Right Choice: The Deliberation-Without-Attention
    Effect. Ap Dijksterhuis,\* Maarten W. Bos, Loran F. Nordgren,
    Rick B. van Baaren. Science 17 February 2006: Vol. 311. no. 5763,
    pp. 1005 - 1007.
5.  Greenhalgh T, Peacock R. Effectiveness and efficiency of search
    methods in systematic reviews of complex evidence: audit of primary
    sources BMJ, Nov 2005; 331: 1064 - 1065.
6.  Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR; Hedges
    Team. Optimal search strategies for retrieving scientifically strong
    studies of treatment from Medline: analytical survey. BMJ. 2005 May
    21;330(7501):1179. Epub 2005 May 13.
7.  Straus SE, Ball C, Balcombe N, Sheldon J, McAlister FA. Teaching
    evidence-based medicine skills can change practice in a community
    hospital. J Gen Intern Med. 2005 Apr;20(4):340-3.

I will dig out the details of these papers when I get some time.
